Erratum: Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy (Annals of Oncology (2019) 30(7) (1162–1169), (S0923753419312293), (10.1093/annonc/mdz117));Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy

Annals of Oncology

Volumn 30, Issue 7, 2019, Pages 1162-1169

  Pastorino, U ^a   Silva, M ^a,b   Sestini, S ^a   Sabia, F ^a   Boeri, M ^a   Cantarutti, A ^c   Sverzellati, N ^b   Sozzi, G ^a   Corrao, G ^c   Marchiano A ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

early detection; low dose computed tomography; lung cancer; mortality; overdiagnosis; screening

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; EARLY CANCER DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; LOW ENERGY RADIATION; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY RISK; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; TREATMENT DURATION; TREATMENT OUTCOME; MORTALITY RATE; PROSPECTIVE STUDY; RISK FACTOR; TREND STUDY; CLINICAL TRIAL; EPIDEMIOLOGY; ITALY; LUNG TUMOR; MORTALITY; MULTICENTER STUDY; NON SMALL CELL LUNG CANCER; PROGNOSIS; SMALL CELL LUNG CANCER; SURVIVAL RATE;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; HUMANS; ITALY; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; SMALL CELL LUNG CARCINOMA; SURVIVAL RATE;

EID: 85071173152     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdz169     Document Type: Erratum

References (26)

1. National Lung Screening Trial Research Team, Aberle DR, Adams AM et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011; 365: 395-409.
2. Infante M, Cavuto S, Lutman FR et al. Long-term follow-up results of the DANTE trial, a randomized study of lung cancer screening with spiral computed tomography. Am J Respir Crit Care Med 2015; 191(10): 1166-1175.
3. Wille MM, Dirksen A, Ashraf H et al. Results of the randomized Danish lung cancer screening trial with focus on high-risk profiling. Am J Respir Crit Care Med 2016; 193(5): 542-551.
4. Pastorino U, Rossi M, Rosato V et al. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev 2012; 21(3): 308-315.
5. Scholten ET, Horeweg N, de Koning HJ et al. Computed tomographic characteristics of interval and post screen carcinomas in lung cancer screening. Eur Radiol 2015; 25(1): 81-88.
6. Paci E, Puliti D, Lopes Pegna A et al. Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial. Thorax 2017; 72(9): 825-831.
7. Becker N, Motsch E, Gross ML et al. Randomized study on early detection of lung cancer with MSCT in Germany: Results of the first 3 years of follow-up after randomization. J Thorac Oncol 2015; 10(6): 890.
8. Field JK, Duffy SW, Baldwin DR et al. UK Lung Cancer RCT Pilot Screening Trial: Baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening. Thorax 2016; 71(2): 161-170.
9. Pastorino U, Bellomi M, Landoni C et al. Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results. Lancet 2003; 362(9384): 593-597.
10. Silva M, Prokop M, Jacobs C et al. Long-term active surveillance of screening detected subsolid nodules is a safe strategy to reduce overtreatment. J Thorac Oncol 2018; 13(10): 1454-1463.
11. Sverzellati N, Silva M, Calareso G et al. Low-dose computed tomography for lung cancer screening: Comparison of performance between annual and biennial screen. Eur Radiol 2016; 26(11): 3821-3829.
12. Anderson JR, Cain KC, Gelber RD. Analysis of survival by tumor response. J Clin Oncol 1983; 1(11): 710-719.
13. Tammemagi MC, Lam S. Screening for lung cancer using low dose computed tomography. BMJ 2014; 348: G2253.
14. Infante M, Sestini S, Galeone C et al. Lung cancer screening with low-dose spiral computed tomography: Evidence from a pooled analysis of two Italian randomized trials. Eur J Cancer Prev 2017; 26(4): 324-329.
15. Goffin JR, Flanagan WM, Miller AB et al. Biennial lung cancer screening in Canada with smoking cessation-outcomes and cost-effectiveness. Lung Cancer 2016; 101: 98-103.
16. Patz EF Jr, Greco E, Gatsonis C et al. Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: A retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial. Lancet Oncol 2016; 17(5): 590-599.
17. Van Der Aalst CM, Ten Haaf K, de Koning HJ. Lung cancer screening: Latest developments and unanswered questions. Lancet Respir Med 2016; 4(9): 749-761.
18. Yousaf-Khan U, Van Der Aalst C, de Jong PA et al. Final screening round of the NELSON lung cancer screening trial: The effect of a 2.5-year screening interval. Thorax 2017; 72(1): 48-56.
19. Yousaf-Khan U, Van Der Aalst C, de Jong PA et al. Risk stratification based on screening history: The NELSON lung cancer screening study. Thorax 2017; 72(9): 819-824.
20. Schreuder A, Schaefer-Prokop CM, Scholten ET et al. Lung cancer risk to personalise annual and biennial follow-up computed tomography screening. Thorax 2018; 73(7): 626-633.
21. Sozzi G, Boeri M, Rossi M et al. Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: A correlative MILD trial study. JCO 2014; 32(8): 768-773.
22. Pastorino U, Sestini S; https://clinicaltrials.gov/ct2/show/study/NCT02247453 (13 March 2019, date last accessed).
23. Seijo LM, Peled N, Ajona D et al. Biomarkers in lung cancer screening: Achievements, promises, and challenges. J Thorac Oncol 2019; 14(3): 343-357.
24. Patz EF Jr, Pinsky P, Gatsonis C et al. Overdiagnosis in low-dose computed tomography screening for lung cancer. JAMA Intern Med 2014; 174(2): 269-274.
25. Heleno B, Siersma V, Brodersen J. Estimation of overdiagnosis of lung cancer in low-dose computed tomography screening: A secondary analysis of the Danish lung cancer screening trial. JAMA InternMed 2018; 178(10): 1420-1422.
26. Wood DE. National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines for Lung Cancer Screening. Thorac Surg Clin 2015; 25(2): 185-197.